| Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients (NCT03212742) | Centre Francois Baclesse | 2017-09-04 |
| 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor (NCT02632370) | Constantinos Hadjipanayis | 2016-05-01 |
| Fluorescence and Glioma Heterogeneity (NCT02155452) | Tata Memorial Hospital | 2014-05-01 |
| Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas (NCT02388659) | University of Texas Southwestern Medical Center | 2014-02-01 |
| Clinical Development of MR Spectroscopy and Imaging in Brain Cancers (NCT02731521) | University of Texas Southwestern Medical Center | 2014-01-01 |
| Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas (NCT01670890) | Peking Union Medical College Hospital | 2012-08-01 |
| Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy (NCT01657734) | Universitaire Ziekenhuizen KU Leuven | 2011-09-01 |
| Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma (NCT00879437) | Baylor College of Medicine | 2009-09-01 |
| A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas (NCT00704080) | Sanofi | 2008-08-01 |
| Sunitinib to Treat Recurrent Brain Cancer (NCT00923117) | National Cancer Institute (NCI) | 2008-06-01 |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I (NCT00671801) | M.D. Anderson Cancer Center | 2008-04-29 |
| Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas (NCT00822887) | University of Colorado, Denver | 2007-03-01 |
| Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas (NCT00463073) | Rigshospitalet, Denmark | 2006-08-01 |
| Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas (NCT00590954) | Memorial Sloan Kettering Cancer Center | 2006-05-01 |
| ZD6474 to Treat Advanced Brain Cancer in Patients (NCT00272350) | National Cancer Institute (NCI) | 2005-12-29 |
| Bevacizumab for Recurrent Malignant Glioma (NCT00271609) | National Cancer Institute (NCI) | 2005-12-01 |
| Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00165477) | Dana-Farber Cancer Institute | 2005-09-01 |
| Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas (NCT00074646) | Celgene Corporation | 2003-12-01 |